Détail de l'auteur
Auteur Fiszman M |
Documents disponibles écrits par cet auteur (30)

![]()
Article
Catelain C ; Riveron S ; Papadopoulos A ; Mougenot N ; Jacquet A ; Vauchez K ; Yada E ; Pucéat M ; Fiszman M ; Butler Browne G ; Bonne G ; Vilquin JT | 2013![]()
Article
Catelain C ; Marolleau JP ; Schmid M ; Chapel A ; Khattar P ; Lecourt S ; Larghero J ; Fiszman M ; Vilquin JT | AFM-TELETHON | 2011Human skeletal muscle is an essential source of cellular progenitors with potential therapeutic perspectives deserving further identification and characterization. Aldehyde dehydrogenase type 1A1 (ALDH) belongs to a large family of enzymes invol[...]![]()
Article
Rouger K ; Larcher T ; Dubreil L ; Deschamps JY ; Le Guiner C ; Jouvion G ; Delorme B ; Lieubeau B ; Carlus M ; Fornasari B ; Theret M ; Orlando P ; Ledevin M ; Zuber C ; Leroux I ; Deleau S ; Guigand L ; Testault I ; Le Rumeur E ; Fiszman M ; Cherel Y | 2011Accès au résumé PubMed / to PubMed abstract Transfert de cellules MuStem chez le chien GRMD Le transfert de cellules souches dérivées du muscle représente une nouvelle approche de thérapie cellulaire dans les maladies neuromusculaire[...]![]()
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Catelain C ; Riveron S ; Mougenot N ; Jacquet A ; Papadopoulos A ; Vauchez K ; Bonne G ; Fiszman M ; Vilquin JT | AFM-TELETHON | 2011Cardiac cell replacement has emerged as a potent new therapy by regenerating irreversibly damaged heart areas in the setting of heart failure. Cell therapy approaches have been extensively developed in the indication of ischemic infarction, but [...]![]()
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Praud C ; Vauchez K ; Zongo P ; Fiszman M ; Vilquin JT | 2011Murine myoblast transplantation studies in mouse models have provided encouraging results but have underlined important limitations, such as acute cell death and poor migration capacity, beyond the immunological tolerance of the grafted cells. T[...]![]()
Article
Rouger K ; Larcher T ; Dubreil L ; Deschamps JY ; Le Guiner C ; Jouvion G ; Delorme B ; Lieubeau B ; Carlus M ; Fornasari B ; Theret M ; Orlando P ; Ledevin M ; Zuber C ; Leroux I ; Deleau S ; Guigand L ; Testault I ; Le Rumeur E ; Fiszman M ; Cherel Y | 2011![]()
Article
Lecourt S ; Marolleau JP ; Fromigué O ; Vauchez K ; Andriamanalijaona R ; Ternaux B ; Lacassagne MN ; Robert I ; Boumediene K ; Chereau F ; Marie P ; Larghero J ; Fiszman M ; Vilquin JT | 2010Accès au résumé PubMed / to PubMed abstract![]()
Article
Baligand C ; Vauchez K ; Fiszman M ; Vilquin JT ; Carlier PG | 2009Accès au résumé PubMed / to PubMed abstract![]()
Article
Vauchez K ; Marolleau JP ; Schmid M ; Khattar P ; Chapel A ; Catelain C ; Lecourt S ; Larghero J ; Fiszman M ; Vilquin JT | 2009Accès au résumé PubMed / to PubMed abstract![]()
Article
Sarcolemmopathies are muscular dystrophies caused by defects of proteins located within or near cell membrane. Underlying Pathological mechanisms remain unclear. Nevertheless, in dystrophin deficient mdx mice it has been shown that skeletal musc[...]![]()
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Noirez P ; Mouly V ; Fiszman M ; Keller A ; Dubois C ; Alameddine HS | 2008Fibrosis, characterized by excessive accumulation of extracellular matrix (ECM), is a hallmark of muscle biopsies in several muscular dystrophies such as Congenital (CMD) or Duchenne Muscular Dystrophies (DMD). Cell therapy trials have shown tha[...]![]()
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Khattar P ; Decostre V ; Catelain C ; Schwartz K ; Fiszman M ; Bonne G ; Vilquin JT | 2008Purpose: Islet-1+ cells are cardiogenic and angiogenic progenitors participating to heart formation. The first aim was to locate and quantify these cells in view of potential pre-clinical developments. The second aim was to compare their presenc[...]![]()
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Lecourt S ; Marolleau JP ; Fromigué O ; Vauchez K ; Ternaux B ; Lacassagne MN ; Robert I ; Praud C ; Andriamanalijaona R ; Boumediene K ; Chereau F ; Marie P ; Larghero J ; Fiszman M ; Vilquin JT | 2008Purpose: The comprehension of the human skeletal muscle development, homeostasis and physiopathology, and the set up of new therapeutic tools, mandate the cellular investigation of skeletal muscle compartments. In situ, we assessed the phenotype[...]![]()
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Vauchez K ; Baligand C ; Vilquin JT ; Fiszman M ; Carlier P | 2008Purpose: High spatial resolution and non-invasiveness feature NMR imaging, and may allow longitudinal assessment of cell therapies. However, cells must be pre-loaded with an appropriate NMR contrast agent (CA). We compared the ability of two cla[...]![]()
Article
![]()
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Serose A ; Prudhon B ; Salmon A ; Doyennette-Moyne MA ; Fiszman M ; Fromes Y ; Doyennette MA | 2005Communication n° 202 Introduction : As cardiac disorders are a common complication in neuromuscular disorders, it seems essential to treat both skeletal and cardiac muscles in these pathologies. Dilated cardiomyopathies (DCM) are due to progress[...]![]()
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Mongue-Din H ; Salmon A ; Fiszman M ; Fromes Y | 2005Communication n° 201 Familial myopathies are due to primary molecular alterations of striated skeletal and cardiac cells. During cardiomyopathies evolution, patients develop secondary alterations characterized by an abnormal cardiac electric act[...]![]()
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Roques C ; Salmon A ; Serose A ; Fiszman M ; Fattal E ; Fromes Y | 2005Communication n° 203 Background : Concerning myopathies, the treatment of cardiac impairment raises specific issues due to the structure and function of the myocardium. Thus, original routes of administration can be considered as direct injectio[...]![]()
Article
Maurel A ; Azarnoush K ; Sabbah L ; Vignier N ; Le Lorc'h M ; Mandet C ; Bissery A ; Garcin I ; Carrion C ; Fiszman M ; Bruneval P ; Hagège A ; Carpentier A ; Vilquin JT ; Menasché P | 2005Accès au résumé PubMed / to PubMed abstract![]()
Article
![]()
Article
Pouly J ; Hagège AA ; Vilquin JT ; Bissery A ; Rouche A ; Bruneval P ; Duboc D ; Desnos M ; Fiszman M ; Fromes Y ; Menasché P | 2004Accès au résumé PubMed / to PubMed abstract Transplantation de myoblastes dans les cardiomyopathies non ischémiques : premier succès dans un modèle animal (04/11/2004) Les cardiomyopathies dilatées (CMD) globales non ischémiques s[...]![]()
Article
Collectif ; Valero de Bernabe B ; Bittner R ; Blake D ; van Bokhoven H ; Brockington M ; Brown S ; Bushby K ; Campbell KP ; Fiszman M ; Gruenewald S ; Merlini L ; Quijano Roy S ; Romero NB ; Sabatelli P ; Sewry CA ; Straub V ; Talim B ; Topaloglu H ; Voit T ; Yurchenco PD ; Urtizberea JA ; Wewer UM ; Guicheney P | 09/2003![]()
Article
Bertini E ; Bonnemann C ; Brockington M ; Brown S ; Bushby K ; Fiszman M ; Korner C ; Mercuri E ; Merlini L ; Hewitt J ; Quijano Roy S ; Romero NB ; Squarzoni S ; Sewry CA ; Straub V ; Topaloglu H ; Haliloglu G ; Voit T ; Wewer U ; Guicheney P | 20027th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE![]()
Article
Vilquin JT ; Marolleau JP ; Pouzet B ; Garcin I ; Carrion C ; Ternaux B ; Lacassagne MN ; Scorsin M ; Hagège A ; Desnos M ; Duboc D ; Fiszman M ; Schwartz K ; Menasché P | 09/2001